semaglutide 2.4 mg weekly versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Semaglutide Dosage Chart Units: How

When brand-name products are available and accessible, they should be the preferred option due to their established safety, efficacy, and quality standards

Manufacturer direct programs in the US also offer self-pay options around $499/month for uninsured patients (for several GLP-1 / obesity products)

Similarly, the FDA's reviews of the clinical trials, including large outcome studies and observational studies did not find an association between use of GLP-1 RAs and the occurrence of suicidal thoughts or actions

Approximately half of the participants experienced a clinically significant reduction in body weight, although this reduction was mostly less than 10%